MicroTech Medical wins China NMPA approval for AiDEX G9 continuous glucose monitor

PUBT · 2d ago
MicroTech Medical wins China NMPA approval for AiDEX G9 continuous glucose monitor
  • MicroTech Medical received China NMPA marketing clearance for its AiDEX G9 sensor-separated continuous glucose monitoring system.
  • Approval supports commercialization in China, targeting a large diabetes market with 148 million adults living with diabetes in 2024.
  • AiDEX G9 is a next-generation upgrade versus the first model, with improvements in size, portability, and wearing comfort.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MicroTech Medical Hangzhou Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260907-12323653), on September 07, 2026, and is solely responsible for the information contained therein.